Global Allergy Diagnostics Market: Industry Size, Share, Trends, Opportunities Analysis, Key Players, Market Segmentation (By Allergen Type, By Products, By End Users)

Global Allergy Diagnostics Market Analysis, 2017-2025

Market Highlights

A recent report on the market for allergy diagnostics published by Goldstein Research finds that it would rise at a solid 12.74% CAGR during 2017 and 2025 and projecting market’s worth to attain the value of USD 4.1 billion by 2025,. Hitachi Chemical Diagnostics offers extensive service and support in order to provide the patients with a less invasive, world-class allergy diagnosis when internal testing facilities are not available while Morrow Brown Allergy Diagnostics 'prick and wipe' skin allergy testing procedure provides many opportunities for inadvertent occupational exposure with a contaminated sharp. Our report also provide with qualitative information on the factors mentioned below:

• Why allergies remain big business for biotech companies?
• What makes Thermo Fisher Scientific, Quest Diagnostics., BioMerieux, Omega Diagnostics Group, and Stallergenes Greer the major shareholders in Allergy Diagnostics Market?
• What factors are leading developed nations to be disproportionately affected by allergies?
• Why hygiene hypothesis tops the list of risk factor, leaving behind overuse of antibiotics and the avoidance of common allergens by healthy people, which conversely increases their risk?
• What is pushing the companies to redesign the allergy testing processes?
• How companion diagnostics could be the lucrative area for the growth of allergy diagnostics market?

Key Players Mentioned In the Report

Thermo Fisher Scientific, Quest Diagnostics., BioMerieux, Omega Diagnostics Group, Stallergenes Greer, Siemens Healthineers, HAL Allergy Group, Lincoln Diagnostics, Allercheck Inc., Hob Biotech Group, Danaher Corporation, Hycor Biomedical, Hitachi Chemical Diagnostics and many more.

Start-ups Associated: Theranos, Kiweno, etc

Market Segmentation

By Allergen Type

• Inhaled Allergens
• Food Allergens
• Other Allergens (Mention Others)

By Products

• Assay Kits
• Instruments
• Consumables
• Luminometers

By End Users

• Diagnostic Laboratories
• Hospitals
• Academic Research Laboratories
• Other End Users (Mention Others)

North America to Acquire Almost 40% Share of Total Allergy Diagnostics Market By 2025

More than 50 million people in the United States have an allergy of some kind making North America the largest market for allergic diagnostics globally, in terms of value, and occupied nearly 51.4% share of the global market in 2017. The U.S. bears USD 4.3 billion in annual cost to cater to the needs of 42.1 million allergic rhinitis patients and up to USD 0.71 billion in indirect costs due to 4.1 million missed working days. In order to curb such a heavy impact on the U.S. economy, the government is taking certain initiatives and the implementation of allergy awareness and education programs. Moreover, the reimbursement policies in the U.S. comprise of majority of treatment procedures and tests pertaining to allergy diagnosis and treatment through the Medicare and Medicaid Services.

Scope & Study Objectives Of This Report Are:

• Ongoing and forecast period global allergy diagnostics market lookout in the developed and emerging markets
• Analysis of the segment are expected to witness the fastest growth during the forecast period
• To examine market competition scenario including expansions, product launches, generation capacity, item esteem, material parameters, conveyance chain, agreements and merger acquisitions.
• The local regulatory reforms, reimbursement and improvement strategies along with the forecast are clarified in each key point that indicates the general execution and issues in key areas, for example, the US, Asia Pacific, Middle East & Africa and Europe.

Customize Request